Your Article Summary
See Latest ArticlesA Signaling Network in Phenylephrine-induced Benign Prostatic Hyperplasia
Endocrinology, 05/21/09
Kim J et al. - This is the first attempt to develop a comprehensive molecular network for histologic BPH induced by adrenergic activation. The study also implicated clusterin as a novel biochemical target for therapy.
Related Articles
The Impact of Diabetes Type 2 in the Pathogenesis of Benign Prostatic Hyperplasia: A Review
Advances in Urology, 11/10/09
Relevance Score: 85%
Association of Codon 10 Polymorphism of the Transforming Growth Factor Beta 1 Gene with Prostate Cancer and Hyperplasia in an Iranian Population
Urologia Internationalis, 10/16/09
Relevance Score: 84%
Significant Complications following Minimally Invasive Office-Based Treatments for BPH: Experience from a Tertiary Care Center
Current Urology, 11/13/09
Relevance Score: 82%
Intraprostatic injection of botulinum toxin A: A promising treatment for patients with benign prostatic hyperplasia
Indian Journal of Urology, 10/05/09
Relevance Score: 82%
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia
Cochrane Reviews, 10/20/09
Relevance Score: 80%
Today in Adrenal Glands...keeping you current
Receive free subspecialty "5-minute updates" via email
Abscess of adrenal gland caused by dissiminated subacute Nocardia farcinata pneumonia. A case report and mini-review of the literature
BMC Infectious Diseases, 12/03/09
Energy-based hemostatic devices in laparoscopic adrenalectomy
Langenbeck's Archives of Surgery, 12/02/09
Diagnosis of Adrenal Insufficiency Using the GHRP-6 Test: Comparison with the Insulin Tolerance Test in Patients with Hypothalamic-Pituitary-Adrenal Disease
Hormone and Metabolic Research, 12/02/09
Today in Endocrine...keeping you current
Receive free subspecialty "5-minute updates" via email
Oestrogenic mycotoxin exposures and precocious pubertal development
International Journal of Andrology, 12/03/09
Kisspeptin/GPR54 system as potential target for endocrine disruption of reproductive development and function
International Journal of Andrology, 11/13/09
Timetable of effects of testosterone administration to hypogonadal men on variables of sex and mood
The Aging Male, 11/13/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09
Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature
European Urology, 12/04/09